Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
We are very excited to launch our new website! Please take a few moments to click around and explore...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...